Annual Charles Cully Memorial Lecture & Medal Award 2017

Date: 
December 06th, 2017

Venue: Witness Gallery, GPO, O’Connell Street Lower, Dublin 1

Each year the Irish Cancer Society holds a Charles Cully Memorial Lecture. The lecture recognises and awards leadership in the fields of cancer control, cancer prevention, and health policy and provides an opportunity to highlight best practice or innovation in those areas.

The Irish Cancer Society has commissioned research from the National Cancer Registry of Ireland to establish the proportion of cancers diagnosed via emergency presentation across the top ten cancers. Preliminary findings of this important research will be launched at this year’s Annual Charles Cully Memorial Lecture.

This year, we have chosen to focus on the late diagnosis of lung cancer, for a number of reasons. We know from UK data that 34% of lung cancers patients are diagnosed as an emergency, lowering survival rates. Irish data shows that that 2 out of 3 lung cancers are diagnosed at a late stage.

In addition to this the National Cancer Strategy 2017-2026, has a number of targets relating to the earlier diagnosis of lung cancer, and seeks to significantly reduce the number of cancers diagnosed in Emergency Departments.

We have chosen to honour Professor Mick Peake as this year’s Charles Cully Medal Recipient in recognition of his lifelong work on earlier diagnosis and improved outcomes for lung cancer patients.

Programme

9.30am – 9.45 am: Donal Buggy, Head of Services & Advocacy, Irish Cancer Society 

Introduction & overview of Irish Cancer Society funded National Cancer Registry of Ireland research - proportion of cancers diagnosed by emergency presentation across the top ten cancers

9.45am -10.30am: Charles Cully Memorial Lecture

‘Towards the earlier diagnosis and improved outcomes of lung cancer patients’ by Professor Mick Peake

Professor Peake will focus on:

  • optimising the early diagnosis of lung cancer
  • national and international statistics around survival and late diagnosis
  • the experience and impact of the public awareness campaigns
  • the scale and problem of emergency presentations
  • efforts to promote the optimisation of the lung cancer care pathway

10.30am-10.45am: Q&A

10.45am- 11.15am: Tea & Coffee

Charles Cully Medal Recipient 2017

Professor Mike Peake 

Professor Peake is the Clinical Lead for Early Diagnosis in Public Health England’s National Cancer Registration and Analysis Service where he helps oversee the clinical understanding and analysis of UK-wide population data on cancer. 

He is an Honorary Consultant and Professor of Respiratory Medicine in the University Hospitals of Leicester. He is also the Director of the Centre for Cancer Outcomes, University College London Hospitals (UCLH) Cancer Collaborative. 

He has had a major interest in lung cancer and mesothelioma for many years. He established the National Lung Cancer Audit (NLCA) in the Royal College of Physicians where he was Associate Director of the Clinical Effectiveness and Evaluation Unit for 20 years. He has recently stepped down as Clinical Lead for the NLCA. He was National Clinical Lead for Lung Cancer and for NHS Cancer Improvement from 2001 - 2013. 

He has been involved in the development and implementation of national cancer policy in England since the late 1990s. He has published widely with his major interests being in early diagnosis and improving outcomes for cancer patients by proper service configuration, supported by good clinical outcome data. 

The Charles Cully Lecture and Medal Award is an annual event held by the Irish Cancer Society. The lecture recognises and awards leadership in the field of cancer control, cancer prevention, or health policy and provides an opportunity to highlight best practice or innovation in those areas. The lecture takes its name from one of the most influential founding members of the Irish Cancer Society.